Safeguarding Vulnerable Populations in Rare Disease Research
Safeguarding Vulnerable Populations in Rare Disease Research Protecting Vulnerable Groups in Rare Disease Clinical Research Why Vulnerability Matters in Rare Disease Trials Rare disease clinical trials often involve highly vulnerable populations, such as children, individuals with cognitive impairments, economically disadvantaged patients, or those with severely debilitating conditions. These groups face unique risks of exploitation or…
Read More “Safeguarding Vulnerable Populations in Rare Disease Research” »